| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/18/2013 | US20130096113 Heterocyclic compounds and methods of use thereof |
| 04/17/2013 | CN103044310A Indoline-3-acetic acid derivative and preparation method thereof as well as application of derivative in medicine |
| 04/17/2013 | CN103041299A Traditional Chinese medicine for treating hyperthyroidism |
| 04/17/2013 | CN103041212A Hyperthyroidism inhibition pill |
| 04/17/2013 | CN103040972A Traditional Chinese medicine formula for treating hyperthyroidism |
| 04/17/2013 | CN103040880A Separation and purification method of tribulus terrestris saponin |
| 04/17/2013 | CN103040866A Extract containing conjugated estrogens and extraction and purification method of extract |
| 04/17/2013 | CN102397465B Traditional Chinese medicine for treating nanism, activating self growth potential, invigorating brain and increasing intelligence |
| 04/17/2013 | CN101647850B New application of chemical component of eucommia bark used as plant estrogen |
| 04/16/2013 | US8420679 Aminothiazole derivatives and their use as CRF receptor ligands |
| 04/16/2013 | CA2541090C Use of indole acetic acid or derivatives thereof to increase igf-1 serum levels |
| 04/16/2013 | CA2431521E Steroid hormone products and methods for preparing them |
| 04/11/2013 | WO2013023040A3 Stem cell therapy using inhibitors of lysophosphatidic acid |
| 04/11/2013 | WO2013010048A3 Non-standard insulin analogues |
| 04/11/2013 | WO2012174478A3 Stable formulations of a hyaluronan-degrading enzyme |
| 04/10/2013 | EP2575865A1 Pharmaceutical composition comprising ave0010 and insulin glargine |
| 04/10/2013 | EP2575859A1 Methods of treating diabetes and compositions capable of same |
| 04/10/2013 | EP2575853A1 Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient |
| 04/10/2013 | CN103038250A 胰高血糖素类似物 Glucagon analogs |
| 04/10/2013 | CN103037891A Methods of treating diabetes and compositions capable of same |
| 04/10/2013 | CN103037862A Methods of treating or preventing estrogen-related diseases |
| 04/10/2013 | CN103030617A Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 04/10/2013 | CN103028118A Drug carriers, their synthesis, and methods of use thereof |
| 04/10/2013 | CN103028024A Preparation method of prescription for treating chronic adrenocortical hypofunction |
| 04/10/2013 | CN103028016A Preparation technology and production method of integrated new dosage form of Pinellia Tuber and sulfur pill |
| 04/10/2013 | CN102204894B Iodized lecithin enteric capsule preparation and preparation method thereof |
| 04/10/2013 | CN101745017B Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof |
| 04/10/2013 | CN101745016B Extraction method of 'ginseng/radix ophiopogonis and schisandra chinensis' and preparation thereof |
| 04/10/2013 | CN101745015B Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof |
| 04/10/2013 | CN101745007B Extraction method of 'radix ophiopogonis/ginseng and schisandra chinensis' and preparation thereof |
| 04/10/2013 | CN101744992B Extraction method of ginseng, ophiopogon root and schisandra chinensis and preparation thereof |
| 04/10/2013 | CN101744991B Single extraction method of ginseng, ophiopogon root and shiandra and preparation thereof |
| 04/09/2013 | CA2383470C Inhibition of secretion from non-neuronal cells |
| 04/04/2013 | WO2013045519A1 Derivatives of 6-substituted triazolopyridazines as rev-erb agonists |
| 04/04/2013 | WO2013045407A1 Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments |
| 04/04/2013 | WO2013005698A9 Biological inorganic compound complex having reduced oxygen and high reducing ability |
| 04/04/2013 | US20130085166 Formulations and uses of retinoic acid receptor selective agonists |
| 04/04/2013 | US20130085148 Pyridine Derivatives |
| 04/04/2013 | US20130084295 Anti-interferon-alpha antibodies |
| 04/04/2013 | CA2850047A1 Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments |
| 04/04/2013 | CA2848518A1 Derivatives of 6-substituted triazolopyridazines as rev-erb agonists |
| 04/03/2013 | EP2440567B1 Substituted 16,17-annellated steroid compounds for use in women's healthcare |
| 04/03/2013 | CN103007055A Hair-blacking beautifying kidney-reinforcing Chinese medicinal herb liquor and preparation method thereof |
| 04/03/2013 | CN103007017A Goiter and stasis removing compound medicine |
| 04/03/2013 | CN103006790A Composition used as sex hormone conditioning agent |
| 04/03/2013 | CN103006685A Coptis chinensis polysaccharide for treating type II diabetes and preparation method thereof |
| 04/03/2013 | CN103006592A Pharmaceutical compositions for glucocorticoid replacement therapy |
| 04/03/2013 | CN102274468B Chinese medicinal composition for regulating female internal secretion and preparation method thereof |
| 04/03/2013 | CN102247471B Application of rehmannia root water extract to preparing estrogen medicament |
| 04/02/2013 | US8410174 Method for treating arthritis |
| 04/02/2013 | US8410132 Modulators of cystic fibrosis transmembrane conductance regulator |
| 04/02/2013 | US8410053 Methods for treating autoimmune disorders, and reagents related thereto |
| 03/28/2013 | WO2013041457A1 N-piperidin-4-yl derivatives |
| 03/28/2013 | WO2013040784A1 Lyophilizing insulin liposome powder, oral insulin complex preparation, preparation method therefor, and use thereof |
| 03/28/2013 | US20130078237 Cd27l antigen binding proteins |
| 03/28/2013 | CA2849109A1 N-piperidin-4-yl derivatives |
| 03/27/2013 | EP2572704A1 Orally-Disintegrating Formulations of Vildagliptin |
| 03/27/2013 | EP2571505A1 Posology and administration of glucocorticoid based compositions |
| 03/27/2013 | CN103002918A Growth hormones with prolonged in-vivo efficacy |
| 03/27/2013 | CN102993309A Human auxin fusion protein TAT-hGH as well as preparation method and application thereof |
| 03/27/2013 | CN102993303A Anti-interferon- alpha antibodies |
| 03/27/2013 | CN102993277A Novel immunomodulatory protein, preparation method and application |
| 03/27/2013 | CN102989001A Pegylated recombinant human growth hormone compounds |
| 03/27/2013 | CN102988995A Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from HIV-TAT |
| 03/27/2013 | CN102988737A Pills for treating hyperthyroidism |
| 03/27/2013 | CN102988395A Application of Houttuynoid E in preparation of medicine for promoting insulin secretion |
| 03/27/2013 | CN102988385A Application of Houttuynoid A to preparation of medicine for treating osteoporosis caused by lack of antiestrogen |
| 03/27/2013 | CN102988381A Application of Houttuynoid A for preparing medicine for promoting insulin to secrete |
| 03/27/2013 | CN102988342A Application of cyclo-icaritin aglycone in preparation of anti-inflammatory and antimicrobial medicaments |
| 03/27/2013 | CN102367243B Stable potassium sodium dehydroandroan drographolide succinate compound and pharmaceutical composition thereof |
| 03/27/2013 | CN102366402B Scopolamine hydrobromide injection and production technology |
| 03/27/2013 | CN102234281B Pyrimidine-fused cyclic derivative |
| 03/27/2013 | CN102228644B Medicament for treating thyrocele and preparation method thereof |
| 03/27/2013 | CN102046646B C-ring-substituted pregn-4-ene-21,17-carbolactone, and pharmaceutical preparations comprising the latter |
| 03/27/2013 | CN101921772B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CN101564512B Quality control method of hyperthyroidism resistance powder |
| 03/27/2013 | CN101137390B Novel angiogensis inhibitor |
| 03/27/2013 | CN101066997B Human antibodies that bind human IL-12 and methods for producing |
| 03/26/2013 | CA2457925C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 03/21/2013 | US20130072522 Process for Making Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 03/21/2013 | US20130072481 mTOR SELECTIVE KINASE INHIBITORS |
| 03/21/2013 | US20130071320 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 03/20/2013 | EP2570436A1 Use of neutralizing prolactin receptor antibodies in combined hormone therapy |
| 03/20/2013 | EP2570435A1 Use of neutralizing prolactin receptor antibodies for the treatment of endometriosis and andenomyosis |
| 03/20/2013 | EP2570136A2 Protein A compositions and methods of use |
| 03/20/2013 | EP2569003A2 Parathyroid hormone analogs and uses thereof |
| 03/20/2013 | EP2568806A1 Therapeutic regimens |
| 03/20/2013 | CN1541107B Growth factor complex |
| 03/20/2013 | CN102977212A Compositions comprising anti-IGF-1r antibodies and methods for their production |
| 03/20/2013 | CN102977018A Application of indenoindene isoquinoline estrogen receptor beta adjustment agent in resisting breast cancer |
| 03/20/2013 | CN102976973A Selective androgen receptor modulator and method for using thereof |
| 03/20/2013 | CN102973764A Traditional Chinese medicine for treating hyperthyroidism |
| 03/20/2013 | CN102973687A Oral liquid for regulating female hormonal balance |
| 03/20/2013 | CN102973430A Surfactant thickened systems comprising microfibrous cellulose and methods of making same |
| 03/20/2013 | CN102166325B Preparation method of Chinese medicine for treating hyperthyroidism |
| 03/20/2013 | CN101669936B Drug combination containing pratensein and application thereof in drugs |
| 03/19/2013 | US8399479 Modulators of cystic fibrosis transmembrane conductance regulator |
| 03/19/2013 | US8399202 Peptides for development of diagnostic and therapeutic agents and methods of using same |
| 03/19/2013 | CA2471702C Human monoclonal antibodies against cd30 |
| 03/14/2013 | WO2013036563A1 Pharmaceutical compositions comprising an aromatase inhibitor |